Emerg Infect Dis by Silva, Jos\ue9 Tiago et al.
strains but was loosely related to genogroup 1, the basis 
of the vaccine used for inoculation against Korean PEDV 
strains. This isolate may need further evaluation as a 
candidate for a vaccine to prevent reemerging PEDVs in 
South Korea.
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To the Editor: Dermacentor-borne necrosis erythema 
lymphadenopathy/tickborne lymphadenopathy (DEBO-
NEL/TIBOLA) is an apparently benign, self-limiting 
rickettsial disease transmitted by Dermacentor ticks (1,2). 
Rickettsia slovaca was the first etiologic agent isolated, but 
other species, such as R. raoultii and Candidatus R. rioja, 
also might be involved (3–6). If the scalp is affected, a larg-
er number of agents (including Francisella tularensis, Bar-
tonella henselae, R. massiliae, R. sibirica mongolitimonae, 
and Borrelia burgdorferi) should be considered within the 
differential diagnosis of a similar syndrome recently named 
scalp eschar associated with neck lymphadenopathy after a 
tick bite (SENLAT) (7). Nevertheless, in Spain, only R. slo-
vaca, Candidatus R. rioja, and F. tularensis are known to 
cause DEBONEL/TIBOLA/SENLAT (4,6). This entity is 
considered an emerging rickettsiosis in Europe; cases have 
been reported from Italy, France, Hungary, Germany, and 
Portugal (8).
We recently saw a patient in whom acute myopericar-
ditis developed after he was bitten by a large tick on the 
scalp and showed clinical signs of DEBONEL/TIBOLA/
SENLAT, most likely attributable to R. slovaca or Candi-
datus R. rioja infection. The patient, a previously healthy 
28-year-old man, went on a day-long hiking trip to the 
northern mountains of Madrid (central Spain; mean altitude 
1,300 m) on November 2, 2014. Three days later, he noticed 
a mild ache on the occipital area of his scalp and found an 
attached tick that he removed with his fingers. A week later, 
he sought care from an infectious disease specialist because 
of itchy discomfort at the area of the tick bite. 
Examination revealed an erythematous and elevated 
punctiform lesion with mild fluctuation in the occipital re-
gion accompanied by tender, small lymph node enlargement 
of both occipital lymphatic chains (Figure). No widespread 
rash was present. DEBONEL/TIBOLA/SENLAT was di-
agnosed, and doxycycline (100 mg every 12 hours) was 
initiated. IgG titer against spotted fever group Rickettsia 
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(SFGR) was 1:128. Four days later, the patient sought care 
at an emergency department, reporting retrosternal chest 
pain. Electrocardiogram revealed a diffuse ST-segment el-
evation with PR-segment depression; serum creatine phos-
phokinase and troponin T levels were 327 IU/L (reference 
range 10–190 IU/L) and 420 ng/mL (reference <14 ng/mL), 
respectively. Myopericarditis was diagnosed. A transtho-
racic echocardiogram ruled out pericardial effusion, valve 
vegetations, and left ventricular dysfunction; cardiovascular 
magnetic resonance imaging performed 4 days later showed 
myocardial inflammation. Blood cultures were sterile, 
pneumococcal urinary antigen test result was negative, and 
IgM against coxsackievirus and Mycoplasma pneumoniae 
were not detected. Nonsteroidal antiinflammatory drugs 
were prescribed. The patient improved clinically, and elec-
trocardiogram findings resolved. The patient received doxy-
cycline for 4 weeks.
On a convalescent-phase serum specimen collected 
after 8 weeks, indirect immunofluorescence assays (IFA) 
for IgG against SFGR were performed in Spain’s national 
reference center for rickettsioses (Hospital San Pedro–
Centro de Investigación Biomédica de La Rioja [CIBIR], 
Logroño, Spain). Commercial (Focus Diagnostics, Cy-
press, CA, USA) and in-house R. conorii, R. slovaca, and 
R. raoultii antibody testing showed an IgG titer of 1:512 
against the 3 species. A subsequent cross-adsorption as-
say using R. slovaca, R. raoultii, and R. conorii antigens 
prepared on the basis of strains from the collection at Hos-
pital San Pedro-CIBIR showed a decrease in IgG titers 
against R. conorii and R. raoultii to 1:64 and 1:256, re-
spectively, whereas titer against R. slovaca remained at 
512. IFA against Bartonella spp. and C. burnetii (Focus 
Diagnostics), chemiluminescence immunoassay for B. 
burgdorferi (Liason, DiaSorin, Spain), and in-house mi-
croagglutination assay for F. tularensis were not reactive. 
The patient recovered, with only a residual scarring alope-
cia on the occipital region of the scalp and without cardiac 
dysfunction after 9-month follow-up.
Myopericarditis is a rare complication of rickettsio-
sis, usually associated with R. rickettsii and R. conorii (9). 
Although tetracycline-induced cardiac adverse reactions 
have been described (10) and the patient reported here had 
signs of myopericarditis shortly after the initiation of doxy-
cycline, he completed a 4-week treatment without recur-
rence. Therefore, the clinical picture seems unlikely to be 
attributable to doxycycline-induced toxicity. Because the 
patient was bitten in November (when only Dermacentor 
spp. ticks are active in central Spain), we have further epi-
demiologic evidence for attributing the infection to SFGR 
causing DEBONEL/TIBOLA/SENLAT. After serum ad-
sorption, IFA titer against R. slovaca was 3-fold higher 
than that against R. conorii. R. slovaca and Candidatus R. 
rioja are the species most commonly found in D. margin-
atus ticks and in cases of DEBONEL/TIBOLA/SENLAT 
in Spain (8).
In view of the seroconversion to Rickettsia spp. with 
negative test results for other possible causative agents and 
the clinical response to doxycycline, rickettsiosis caused by 
R. slovaca or Candidatus R. rioja remains the most prob-
able diagnosis. Because DEBONEL/TIBOLA/SENLAT is 
an emerging disease, physicians should consider that this 
entity may be associated with systemic complications simi-
lar to those of other tickborne rickettsioses.
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Figure. Dermacentor-borne necrosis erythema lymphadenopathy/
tickborne lymphadenopathy/scalp eschar associated with neck 
lymphadenopathy after a tick bite. Shown is an erythematous, 
punctiform lesion in the scalp (arrow), accompanied by enlarged 
occipital lymph nodes. A color version of this figure is available 
online (http://wwwnc.cdc.gov/EID/article/21/12/15-0672-F.htm).
  3. Cazorla C, Enea M, Lucht F, Raoult D. First isolation of Rickettsia 
slovaca from a patient, France. Emerg Infect Dis. 2003;9:135. 
http://dx.doi.org/10.3201/eid0901.020192
  4. Oteo JA, Ibarra V, Blanco JR, Martínez de Artola V, Márquez FJ,  
Portillo A, et al. Dermacentor-borne necrosis erythema and 
lymphadenopathy: clinical and epidemiological features of a new 
tick-borne disease. Clin Microbiol Infect. 2004;10:327–31.  
http://dx.doi.org/10.1111/j.1198-743X.2004.00782.x
  5. Portillo A, Ibarra V, Santibáñez S, Pérez-Martínez L, Blanco JR,  
Oteo JA. Genetic characterisation of ompA, ompB and gltA 
genes from Candidatus Rickettsia rioja. Clin Microbiol Infect. 
2009;15(Suppl 2):307–8. http://dx.doi.org/10.1111/ 
j.1469-0691.2008.02250.x
  6. Pérez-Pérez L, Portillo A, Allegue F, Zulaica A, Oteo JA,  
Caeiro JL, et al. Dermacentor-borne necrosis erythema and  
lymphadenopathy (DEBONEL): a case associated with  
Rickettsia rioja. Acta Derm Venereol. 2010;90:214–5.  
http://dx.doi.org/10.2340/00015555-0801
  7. Dubourg G, Socolovschi C, Del Giudice P, Fournier PE, Raoult D. 
Scalp eschar and neck lymphadenopathy after tick bite: an emerg-
ing syndrome with multiple causes. Eur J Clin Microbiol Infect Dis. 
2014;33:1449–56. http://dx.doi.org/10.1007/s10096-014-2090-2
  8. Oteo JA, Portillo A. Tick-borne rickettsioses in Europe.  
Ticks Tick Borne Dis. 2012;3:271–8. http://dx.doi.org/10.1016/ 
j.ttbdis.2012.10.035
  9.  Shah SS, McGowan JP. Rickettsial, ehrlichial and Bartonella 
infections of the myocardium and pericardium. Front Biosci. 2003; 
8:e197–201. http://dx.doi.org/10.2741/995
10. Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O.  
Comparative analysis of adverse drug reactions to tetracyclines: 
results of a French national survey and review of the literature.  
Br J Dermatol. 2012;166:1333–41. http://dx.doi.org/10.1111/
j.1365-2133.2012.10845.x
Address for correspondence: José Tiago Silva, Unidad de Enfermedades 
Infecciosas, Hospital Universitario “12 de Octubre,” Centro de 
Actividades Ambulatorias, Planta 2ª, Bloque D. Avda de Córdoba, s/n. 
Postal Code 28041, Madrid, Spain; email: j.tiago.silva@hotmail.com
Parainfluenza Virus 5 as  
Possible Cause of Severe  
Respiratory Disease in 
Calves, China
Ye Liu,1 Nan Li,1 Shoufeng Zhang, Fei Zhang,  
Hai Lian, Rongliang Hu
Author affiliations: Laboratory of Epidemiology and Key Laboratory 
of Jilin Province for Zoonosis Prevention and Control, Academy of 
Military Medical Sciences, Changchun, China
DOI: http://dx.doi.org/10.3201/eid2112.141111
To the Editor: Parainfluenza virus 5 (PIV5), fam-
ily Paramyxoviridae, genus Rubulavirus, was previously 
known as simian virus 5 because of its discovery in primary 
monkey kidney cells in 1954 (1). PIV5 was later isolated 
from various hosts, including humans, dogs, pigs, cats, and 
rodents. The neutralizing antibody for PIV5 is detectable 
in symptomatic and asymptomatic humans; thus, its asso-
ciation with human disease remains controversial (2). In 
addition, previous studies have not documented illness in 
infected animals, except kennel cough in dogs (1,3). Isola-
tion of PIV5 from cattle has not previously been reported.
Since 2012, an infectious respiratory disease has been 
prevalent in weaning calves (≈10 d to 2 mo of age) in 
Baicheng City, Jilin Province, China. Initial clinical signs 
included secretion of clear nasal mucus, anorexia, slug-
gishness, and loss of body weight. After 10–20 d, ≈10% of 
the sick calves died of dyspnea and interstitial pneumonia. 
Farmers observed that 80%–90% of calves in the affected 
farms demonstrated clinical signs, but most recovered. All 
attempts of local veterinarians to treat the animals with var-
ious chemical compounds and antimicrobial drugs failed. 
The disease persists throughout the year but occurs mainly 
during spring (from February through March), which has 
resulted in substantial economic losses in the cattle industry.
To identify the causative agent of the disease, we test-
ed 15 lung samples from calves that had died and 10 lung 
samples from healthy calves that were slaughtered for se-
rum products (all from 1 farm). The samples were homog-
enized in phosphate-buffered saline and analyzed by using 
electron microscopy. Paramyxovirus-like particles were 
identified in the tissues of sick calves. Reverse transcrip-
tion PCR with the generic primers for the paramyxovirus 
polymerase gene was performed (4).
Of the 25 calf specimens, the 15 samples from the 
sick calves were positive by reverse transcription PCR, 
and amplicons of the expected size were obtained and se-
quenced. The generated sequences were closely related to 
the PIV5 sequences available from GenBank, particularly 
to sequences of the recently identified KNU-11 and SER 
viruses in pigs (5,6).
The suspensions of lung tissue from sick calves were 
purified by centrifugation at 12,000 × g for 5 min, and 0.2 
mL of the supernatant was added to a Vero cell monolayer 
in a 25-cm2 cell culture flask (EasyFlasks; Thermo Fisher 
Scientific, Odense, Denmark). After virus adsorption for 1 
h at 37°C, the cell monolayer was rinsed with phosphate-
buffered saline (pH 7.4) and then incubated in Dulbecco 
minimal essential medium/2% newborn calf serum at 37°C 
in a 5% CO
2
-humidified incubator. The infected cells were 
serially passaged every 3 days at 37°C and detected by us-
ing monoclonal antibody against SV5 (AbD Serotec; Bio-
Rad, Kidlington, UK) by indirect fluorescent antibody test 
(7). A PIV5 strain was isolated in the cell culture and desig-
nated PIV5-BC14 (BC14 stands for Baicheng City 2014).
For amplification and analysis of the full-length vi-
ral genome, 13 pairs of primers covering overlapping 
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